Related references
Note: Only part of the references are listed.Proteasome dysfunction under compromised redox metabolism dictates liver injury in NASH through ASK1/PPARγ binodal complementary modules
Debajyoti Das et al.
REDOX BIOLOGY (2021)
The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
Gholamreza Daryabor et al.
FRONTIERS IN IMMUNOLOGY (2020)
Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
Xiaoyan Li et al.
CELL AND BIOSCIENCE (2020)
S100A4 promotes inflammation but suppresses lipid accumulation via the STAT3 pathway in chronic ethanol-induced fatty liver
Qi Yuan et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells
Elizabeth Haythorne et al.
NATURE COMMUNICATIONS (2019)
Hepatocytes derived extracellular vesicles from high-fat diet induced obese mice modulate genes expression and proliferation of islet β cells
Qi Fu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals
Malte P. Suppli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2019)
S100A6 Promotes B Lymphocyte Penetration Through the Blood-Brain Barrier in Autoimmune Encephalitis
Meng-Han Tsai et al.
FRONTIERS IN GENETICS (2019)
The implication of hepatokines in metabolic syndrome
Maryam Esfahani et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes et al.
HEPATOLOGY (2018)
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
Alessandro Mantovani et al.
DIABETES CARE (2018)
Activin E Controls Energy Homeostasis in Both Brown and White Adipose Tissues as a Hepatokine
Osamu Hashimoto et al.
CELL REPORTS (2018)
Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells
Li Ma et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice
Tara Jois et al.
MOLECULAR METABOLISM (2017)
SerpinB1 Promotes Pancreatic β Cell Proliferation
Abdelfattah El Ouaamari et al.
CELL METABOLISM (2016)
Effects of RAGE-Specific Inhibitor FPS-ZM1 on Amyloid-β Metabolism and AGEs-Induced Inflammation and Oxidative Stress in Rat Hippocampus
Yan Hong et al.
NEUROCHEMICAL RESEARCH (2016)
Modeling of Glucose-Induced cAMP Oscillations in Pancreatic β Cells: cAMP Rocks when Metabolism Rolls
Bradford E. Peercy et al.
BIOPHYSICAL JOURNAL (2015)
S100A4 promotes liver fibrosis via activation of hepatic stellate cells
Lin Chen et al.
JOURNAL OF HEPATOLOGY (2015)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Glucagon Regulates Hepatic Kisspeptin to Impair Insulin Secretion
Woo-Jin Song et al.
CELL METABOLISM (2014)
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic
Kareem Hassan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
S100A14 Promotes the Growth and Metastasis of Hepatocellular Carcinoma
Fu-Tao Zhao et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Metabolic Signaling in Fuel-Induced Insulin Secretion
Marc Prentki et al.
CELL METABOLISM (2013)
Functions of S100 Proteins
R. Donato et al.
CURRENT MOLECULAR MEDICINE (2013)
Diabetes Mellitus and the β Cell: The Last Ten Years
Frances M. Ashcroft et al.
CELL (2012)
The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans
Fadila Benhamed et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic β-cells
Yunxia Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis
Lucie Andres Cerezo et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: the Central Role of Nontriglyceride Fatty Acid Metabolites
Brent A. Neuschwander-Tetri
HEPATOLOGY (2010)
Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases
Athan Baillet et al.
RHEUMATOLOGY (2010)
Binding of S100 proteins to RAGE: An update
Estelle Leclerc et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Plasma fetuin-A levels and the risk of type 2 diabetes
Norbert Stefan et al.
DIABETES (2008)
Regulation of Pancreatic β Cell Mass by Neuronal Signals from the Liver
Junta Imai et al.
SCIENCE (2008)
β-cell mitochondria exhibit membrane potential heterogeneity that can be altered by stimulatory or toxic fuel levels
Jakob D. Wikstrom et al.
DIABETES (2007)
Profiling of apoptotic changes in human breast cancer cells using SELDI-TOF mass Spectrometry
Sharon Leong et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2007)
Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways
Wolf Wente et al.
DIABETES (2006)
Angiopoietin-related growth factor antagonizes obesity and insulin resistance
Y Oike et al.
NATURE MEDICINE (2005)
Management of Type 2 Diabetes Mellitus: Is It Time for a Paradigm Shift?
Kathleen L. Wyne
METABOLIC SYNDROME AND RELATED DISORDERS (2004)
Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice models
A Boom et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
β-cell mitochondria and insulin secretion -: Messenger role of nucleotides and metabolites
CB Wollheim et al.
DIABETES (2002)
Mitochondrial function in normal and diabetic β-cells
P Maechler et al.
NATURE (2001)
Nonalcoholic steatohepatitis: Definition and pathology
EM Brunt
SEMINARS IN LIVER DISEASE (2001)
Share Paper
